title: Central retinal vein occlusion: a review.
abstract: Central retinal vein occlusion remains a common cause of unilateral visual loss. Until recently, our treatment options for this condition were limited only to laser photocoagulation for the devastating end sequelae of anterior segment neovascularization. Over the last 2 years, a number of randomized controlled trials have given us significant new treatment options to address not only visual loss from macular oedema but also the ability to create a bypass around the obstruction in the central retinal vein and to address the raised venous hydrostatic pressure. In the future, it is likely that combination approaches to the management of central retinal vein occlusion will develop using specific agents and techniques to address the components of macular oedema, retinal ischaemia and raised venous hydrostatic pressure, all of which combine to produce the clinical picture and the reduction in vision seen in this condition.
authors: Lions Eye Institute, Centre for Ophthalmology and Visual Science, University of Western Australia, Nedlands, Western Australia, Australia. ianmcallister@lei.org.au
authors: Ian L
authors: IL
authors: McAllister
mesh_terms: D000714:Anastomosis, Surgical; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D019299:Decompression, Surgical; D006801:Humans; D017075:Laser Coagulation; D012170:Retinal Vein Occlusion / Q000150:complications* / Q000628:therapy; D012307:Risk Factors; D014786:Vision Disorders / Q000209:etiology
chemical_list: D020533:Angiogenesis Inhibitors